Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV‐CHEP) for the treatment of aggressive adult T‐cell leukaemia/lymphoma
Sign Up to like & getrecommendations! Published in 2025 at "British Journal of Haematology"
DOI: 10.1111/bjh.20177
Abstract: with other commonly used regimens. Because of the rarity of this disease, this effort will require incredible international coordination between sites in the United States, Latin America, Europe and Japan. Additionally, newer immunotherapies and targeted… read more here.
Keywords: multicentre pilot; evaluating brentuximab; pilot study; study evaluating ... See more keywords